Is patient engagement just a monologue instead of a dialogue?
Read More
Healthcare IT’s Achilles Heel: Sensors
Healthcare IT’s Achilles Heel: Sensors (via slashdot)
I’ve been wearing a Nike FuelBand for about a week now, and it’s already changed how I view so-called “Big Data.” For several quarters, tech publications and pundits alike have crowed about the benefits we’re soon to collectively reap from…
Read More
Athenahealth’s Jonathan Bush Talks Emerging Technologies in Healthcare
Jonathan Bush, CEO and President of Athenahealth, provides his insights on deploying cloud-based services for more efficient, personalized health-care services.
Read More
Clinithink Receives Mediwales 2013 Innovation Judges’ Award
Clinithink, a world-leader in clinical natural language processing (CNLP) technology, today announced that it received the 2013 MediWales Innovation Judges’ Award.
Read More
Wearable Medical Devices Market Expected to Reach $5.8B Globally by 2019
The global wearable medical devices market is expected to reach $5.8 billion in 2019 and growing at a CAGR of 16.4% between 2013 and 2019...
Read More
72% of Consumers Are Willing to See a Doctor Via Telehealth Video Conferencing
72 percent of consumers across the eight countries are willing to see a doctor via telehealth video conferencing for non-urgent appointments, according to a recent Intel survey.
Read More
AARP and StartUp Health Report: Digital Health Insights for the 50+ Market
AARP and StartUp Health have teamed up to release the first ever digital health funding insights report evaluating the 50+ market.
Read More
Stage 3 Meaningful Use Should Incorporate Criteria to Reduce Disparities, Advocates Say
The National Partnership for Women & Families states the extra time associated with announced delay in stage 3 Meaningful Use must be used to advance consumer goals.
Read More
CMS Proposes Stage 2 and 3 Meaningful Use Extension
The Centers for Medicare & Medicaid Services (CMS) today proposed a new timeline for the implementation of meaningful use.
Read More
Cerner Partners With Claritas Genomics to Accelerate Personalized Medicine
Cerner Corp and Claritas Genomics announce that they will collaborate to advance personalized medicine by developing a rapid, scalable laboratory solution for molecular diagnostics.
Read More
